GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
02 mars 2023 07h00 HE
|
GH Research PLC
DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
NeuroSigma Announces New Telehealth Option for Patients and Caregivers Interested in eTNS for Pediatric ADHD
01 mars 2023 11h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, March 01, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced a new option for patients and caregivers seeking a telehealth evaluation for the Monarch eTNS System®. NeuroSigma is a Los...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
03 févr. 2023 00h01 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
Ehave Provides Progress Update on its HPPD Study with University of Melbourne
02 févr. 2023 08h30 HE
|
Ehave
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to...
Depression Treatment Market will manager to achieve USD 15.0 billion by 2030 : GreyViews
24 janv. 2023 11h30 HE
|
GreyViews
Pune India, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Canadian Men’s Health Foundation expands MindFit Toolkit to support more men with anxiety and depression
19 janv. 2023 08h00 HE
|
Canadian Men's Health Foundation
VANCOUVER, British Columbia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The Canadian Men’s Health Foundation (CMHF) announced today new and expanded mental health resources for their MindFit Toolkit...
FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
18 janv. 2023 13h05 HE
|
Magstim EGI
MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...
Mental Health Technologies Celebrates Mental Wellness Month
17 janv. 2023 15h00 HE
|
Mental Health Technologies (MHT)
AURORA, Ill., Jan. 17, 2023 (GLOBE NEWSWIRE) -- At Mental Health Technologies (MHT), they bring awareness to mental health concerns daily. However, each year everyone goes from the hustle and bustle...
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
09 janv. 2023 07h30 HE
|
GH Research PLC
Initial approvals received for Phase 2b trial of GH001 in TRD (GH001-TRD-201), initiation of this trial expected in Q1 2023Development of proprietary aerosol delivery device for GH001 progressed, IND...
Nexstim Receives an Order for Two NBT® Systems from Canada
14 déc. 2022 03h45 HE
|
Nexstim Oyj
Press release, Helsinki, 14 December 2022 at 10:45 AM (EET) Nexstim Receives an Order for Two NBT® Systems from Canada Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it...